Live Breaking News & Updates on Kiran somvanshi

Stay informed with the latest breaking news from Kiran somvanshi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Kiran somvanshi and stay connected to the pulse of your community

Food companies view India as the new Wild West

Baby foods have sugar added to them, protein powders dont have enough proteins and our good old spices could have ingredients that are carcinogenic. ETs Kiran Somvanshi spoke to New York-based award-winning journalist Michael Moss whose investigation of the processed foods industry culminated in the best-selling book - Sugar, Salt, Fat.

India , United-states , China , Mexico , American , Kiran-somvanshi , Michael-moss , New-york-based , General-foods , Nutrition-facts-box , Sugar-salt-fat , Michael-moss-author

Morning Brief Podcast: What's wrong with India's processed food industry?

Alarmed by recent reports of questionable ingredients in baby food, protein powders, and even masalas, The Morning Brief podcast delves into the state of India's processed food industry and its product safety system. Host Kiran Somvanshi dissects the issue with Dr. Arun Gupta, convenor of Nutrition Advocacy in Public Interest or NAPi, Award-winning journalist Michael Moss, author of ‘Sugar, Salt, Fat’ and ET’s Ratna Bhushan. Together they probe into the condition of India’s broken food safety. Is it a case of not having food safety laws? Or is it about their poor enforcement? What prompts multinational companies from adopting discriminatory food standards across their different markets? And what should we in India be most worried about? Tune in to this must-listen episode!

India , Michael-moss , Ratna-bhushan , Kiran-somvanshi , Arun-gupta , Morning-brief , Nutrition-advocacy , Public-interest , Read-mores , Protein-powders , Product-safety-system

Morning Brief Podcast: Is India's audit profession at a point of inflection? The challenges and the future

India's audit profession is at a critical juncture. From risks rising for auditors, increased public scrutiny, audit fees becoming a bone of contention and a decline in students pursuing Chartered Accountancy.. the list of challenges galore. However, the National Financial Reporting Authority (NFRA) is driving positive change, and the demand for specialized forensic audits is growing. Host Kiran Somvanshi explores the challenges and the rewards of this profession with Vishesh Chandiok, CEO - Grant Thornton Bharat LLP. They also discuss the impact of new technologies that are revolutionizing the field and whether a career as a Chartered Accountant is still worth it? Tune in to the latest episode of The Morning Brief podcast!

India , Kiran-somvanshi , Vishesh-chandiok , Read-morent-thornton-bharat , National-financial-reporting-authority , Chartered-accountancy , Chartered-accountant , Morning-brief ,

Morning Brief Podcast: DRL at 40: Corner office conversation with Co-Chairman & MD, G.V. Prasad

Celebrating 40 years, Dr Reddy's Laboratories stands out in the Indian pharma industry for its focus on governance and innovation. Founded in 1984 by scientist Dr Anji Reddy, the company has had a history of bold moves like early public listing, investing in drug discovery or hiring an expat CEO. Little wonder that the company has ended up being a CEO factory for the Indian pharma industry. The company has also been open about its mistakes and challenges like a large acquisition that fell short of expectations. Join hosts Kiran Somvanshi and Arijit Barman in a candid conversation with G.V. Prasad, Co-Chairman and Managing Director on Dr. Reddy's journey and future on The Morning Brief podcast!

Kiran-somvanshi , Arijit-barman , Read-moreof , Managing-director , Morning-brief , Morning-brief-podcast , Indian-pharma-industry , Drl-public-listing , Drl , Dr-reddys-laboratories , Dr-anji-reddy

Morning Brief Podcast: Uniform Civil Code: Why the division in uniformity?

As Uttarakhand clears it's uniform civil code, it raises questions about whether India needs a Uniform civil code and if so why now and in which form? Is uniformity a camouflage for oppression of religious rights or is the political debate drowning the need for a more modern and progressive civil society in India? Host Kiran Somvanshi gets answers from Senior Advocate Dushyant Dave, legal experts Arghya Sengupta, and Mihira Sood, along with ET’s Anubhuti Vishnoi in the latest episode of The Morning Brief podcast. Tune in!

India , Uttarakhand , Uttaranchal , Arghya-sengupta , Kiran-somvanshi , Anubhuti-vishnoi , Dushyant-dave , Host-kiran-somvanshi , Senior-advocate-dushyant-dave , Mihira-sood , Morning-brief

Morning Brief Podcast: The Religare Rollercoaster: Burmans vs Saluja and Board

What is the conflict between Burmans and the board of Religare that took just one knight to push through an open offer to get a seat at the table? Why did the board, amid questions of compensations and ESOP, back the CEO and sideline the single largest shareholder? Tune in as Arijit Barman and Kiran Somvanshi break down a corporate takeover that has become a full-blown, all-out war between a doctor and the Daburs. Throw in the board, a betting scam, ED sleuths, and SEBI in the mix, and you have a blockbuster battle. What can the board do, and whose court does the ball move to next? Shriram Subramanian, Founder & MD of InGovern, and ET’s Reena Zachariah and Rashmi Rajput break it down with the TMB hosts. Credits: CNBC-TV18 1, CNBC-TV18 2

Rashmi-rajput , Kiran-somvanshi , Reena-zachariah , Arijit-barman , Shriram-subramanian , Read-morea , Sebi , Religare , Morning-brief-podcast , Ed-sleuths , Dabur

Aparajitha Corporate Services: Exploring global opportunities: Aparajitha's expansion plans in Southeast Asia

Aparajitha Corporate Services aims to be a billion-dollar organization in five years with the help of strategic partner Xcelerate Singapore. They are looking at inorganic growth opportunities through acquisitions, including the compliance business of ADP India and Simpliance. They are also in discussions for four other potential acquisitions.

India , Bangalore , Karnataka , Kozhikode , Kerala , Kiran-somvanshi , Aditya-birla , Nagaraj-krishnan , Offering-college , Accenture , Aparajitha-corporate-services , Twitter

Morning Brief Podcast: Family Feuds: From Living Room to Boardroom

The Singhania scandal and saga may be the headlines right now but Indian family feuds have seen showbiz scale drama over the past 2 decades. As siblings and spouses squabble, the silent sufferers are the shareholders. In this episode Host Kiran Somvanshi questions the role of the board and regulation that needs to step in to ensure living room battles don't impact the boardroom. Weighing in on the matter industry veteran Harsh Mariwala, Chairman - Marico and advisor to many family settlements Ketan Dalal, Managing Director - Katalyst Advisors. Tune in!

Moretan-dalal , Kiran-somvanshi , Host-kiran-somvanshi , Harsh-mariwala , Read-moretan-dalal , Managing-director , Morning-brief-podcast , Living-room-to-boardroom , Indian-family-disputes , Family-feuds , Business-partnership-disputes

Morning Brief Podcast: Long work hours: Productive or punitive? | The Economic Times Podcast

Infosys CEO Narayana Murthy’s statement over working hours has snowballed into not just social media arguments, but also reached the boardrooms, while many industry captains align with Murthy's vision of what it takes to build and grow, others talk about the much-needed balance and not stretching till you break. So, the biggest question here is – Is productivity calculated by the clock? Host Prachi Verma speaks with Rajesh Padmanabhan, a Business Transformation Specialist, ET’s Kiran Somvanshi and a few employees who have faced burnout and those who chose to balance their work-life. Listen to the latest episode of The Morning Brief podcast!

Rajesh-padmanabhan , Prachi-verma , Narayana-murthy , Kiran-somvanshi , Host-prachi-verma , Business-transformation-specialist , Read-morend , Morning-brief , Work-hours , Social-media , Snowballed

Morning Brief Podcast: Semaglutide: Decoding the hype around the weight loss wonder drug

From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becoming a $100 bn opportunity by 2030. While the drug’s innovator Novo Nordisk launched its oral version in India last year, Dr. Reddys Laboratories has now got approval to carry out bioequivalence studies of injectable semaglutide. So, what does this mean for India that has a huge disease burden of diabetes and obesity? Is the hype around the drug all worth it? Are there any side effects? Is it affordable? And who should be taking it? Host Kiran Somvanshi tries to understand from Dr. Ambrish Mithal, Chairman & Head - Endocrinology & Diabetes - Max Healthcare, and Nithya Balasubramanian, Director - AB Bernstein. Listen to the latest episode of The Morning Brief podcast!Disclaimer: The analyst interviewed has a financial interest in Cipla and Lupin.Credits: Ozempic Commercial and Jimmy Kimmel Live

India , Hollywood , California , United-states , Nithya-balasubramanian , Ambrish-mithal , Kiran-somvanshi , Novo-nordisk , Cipla , From-elon-musk , Reddys-laboratories , Host-kiran-somvanshi